Form 13-F position report

INVO BIOSCIENCE INC

Reported by WELLS FARGO & COMPANY MN

NAYA CUSIP 44984F401 Manager CIK 0000072971

Reported 18 shares, up 1 (5.9%) from the prior quarter.

Reported value -13.0%; share count 5.9% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q1 2024
Shares 18 Quarter-end amount reported
Reported value $20 Fair value at quarter end
Consecutive quarters held 3 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-09-30 13
2023-12-31 23
2024-03-31 20
2024-06-30 0
2024-09-30 178
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for INVO BIOSCIENCE INC held by WELLS FARGO & COMPANY MN.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -250 (-100.0%) 0 $0 2025-02-13
Q3 2024 New 250 +250 (0.0%) < 0.01% $178 2024-11-13
Q2 2024 Reduced 0 -18 (-100.0%) 0 $0 2024-08-13
Q1 2024 Added 18 +1 (5.9%) < 0.01% $20 2024-05-10
Q4 2023 Added 17 +1 (6.3%) < 0.01% $23 2024-02-09
Q3 2023 New 16 +16 (0.0%) < 0.01% $13 2023-11-13

Who else reported the position

13 managers reported INVO BIOSCIENCE INC for Q1 2024.

Managers reporting INVO BIOSCIENCE INC in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Unchanged 54,058 0 < 0.01% $61,086 2 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 24,852 -1,974 < 0.01% $26,840 3 qtrs
SABBY MANAGEMENT LLC Unchanged 18,624 0 0.01% $21,045 3 qtrs
UBS Group AG Added 8,102 +947 < 0.01% $9,155 2 qtrs
Tower Research Capital LLC TRC Added 6,922 +1,977 < 0.01% $7,822 3 qtrs
ROYAL BANK OF CANADA Unchanged 538 0 < 0.01% $1,000 3 qtrs
ADVISOR GROUP HOLDINGS INC Unchanged 559 0 < 0.01% $632 3 qtrs
Aspire Private Capital LLC Unchanged 115 0 < 0.01% $130 3 qtrs
MORGAN STANLEY Unchanged 37 0 < 0.01% $42 3 qtrs
WELLS FARGO & COMPANY MN This report Added 18 +1 < 0.01% $20 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 10, 2024
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
18
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.